Pfizer (PFE)
(Delayed Data from NYSE)
$25.62 USD
-0.02 (-0.08%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $25.66 +0.04 (0.16%) 5:20 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PFE 25.62 -0.02(-0.08%)
Will PFE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PFE
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eli Lilly (LLY) Tops Q1 Earnings Estimates
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
Other News for PFE
NEW YORK MARKET CLOSE: Dow hit by new inflationary scare ahead of Fed
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
10 Health Care Stocks With Whale Alerts In Today's Session
Notable companies reporting before tomorrow's open
Pfizer call volume above normal and directionally bullish